Get started
Author

Alexander van Doornewaard

Observed names: A van Doornewaard, A. Van Doornewaard, A. van Doornewaard, Alexander Doornewaard, Alexander van Doornewaard (11125512), Doornewaard, Alexander van, Van Doornewaard, Alexander, van Doornewaard, Alexander
ORCID: 0000-0002-3663-0464
Observed ORCID: 0000-0002-3663-0464
OpenAlex ID: A5048650792
Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review
2021 · Mark H. Rozenbaum, Samuel Large, et al. · Cardiology and Therapy · 145
PDF
Associations between serum potassium and adverse clinical outcomes: A systematic literature review
2019 · Eirini Palaka, Susan Grandy, et al. · International Journal of Clinical Practice · 69
PDF
Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy
2021 · Mark H Rozenbaum, Samuel Large, et al. · Journal of Comparative Effectiveness Research · 21
Estimating the Health and Economic Impact of Improved Management in Prevalent Chronic Obstructive Pulmonary Disease Populations in England, Germany, Canada, and Japan: A Modelling Study
2023 · Elisabeth J Adams, Alexander van Doornewaard, et al. · International Journal of COPD · 9
PDF
Comparative Efficacy and Safety of Fostemsavir in Heavily Treatment-Experienced People With HIV-1
2022 · Sarah-Jane Anderson, Alexander van Doornewaard, et al. · Clinical Therapeutics · 6
PDF
119 Estimating the health benefits of introducing ctDNA next generation sequencing to the diagnostic pathway for advanced lung cancer: A modelling study
2024 · Neal Navani, Alexander van Doornewaard, et al. · Lung Cancer · 2
Estimating Life Years And Quality-Adjusted Life Years In Heavily Treatment-Experienced (HTE) Patients
2017 · P McEwan, O Darlington, et al. · Value in Health · 2
OC-4 Estimating the potential health economic value of universal opt-out HIV testing in emergency departments in Italy: a modelling study
2024 · A d’Arminio Monforte, G d’Ettorre, et al. · Sexually Transmitted Infections
PDF
Supplementary materials: Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy
2024 · Rozenbaum, Mark H, Large, Samuel, et al. · Figshare
POSB141 The Health Benefits of Treatment with Fostemsavir in Highly Treatment Experienced HIV-1 Infected Individuals
2022 · A van Doornewaard, I Jacob, et al. · Value in Health
PDF
PMS15 Estimating the Budget IMPACT of the Introduction of Filgotinib for the Treatment of Rheumatoid Arthritis in the UK
2020 · I. Jacob, A. van Doornewaard, et al. · Value in Health
PRO5 Estimating the Health Benefits of Earlier Diagnosis and Treatment of Transthyretin Amyloid Cardiomyopathy
2020 · M.H. Rozenbaum, S. Large, et al. · Value in Health
PDF
Works count: 16
Citation count: 254
H-index: 5
I10-index: 3
Year
Topic
Type